Advances in crispr/cas gene therapy for inborn errors of immunity

HIGHLIGHTS

• who: Xinyi Liu et al. from the China China have published the research work: Advances in CRISPR/Cas gene therapy for inborn errors of immunity, in the Journal: (JOURNAL)
• what: In this review, the authors focus on DNA editing using CRISPR/Cas; thus, RNA editing will not be included. known genetic defects have been identified, and they have diverse underlying manifestations, such as susceptibility to infections, allergy, autoimmunity, autoinflammation, and malignancy .
• future: With the development of safer and more advanced gene editing tools as well as versatile delivery methods an increasing number of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.